JP2025506729A - チエノピロロトリアジン化合物、それらの調製及びそれらの治療的使用 - Google Patents

チエノピロロトリアジン化合物、それらの調製及びそれらの治療的使用 Download PDF

Info

Publication number
JP2025506729A
JP2025506729A JP2024549135A JP2024549135A JP2025506729A JP 2025506729 A JP2025506729 A JP 2025506729A JP 2024549135 A JP2024549135 A JP 2024549135A JP 2024549135 A JP2024549135 A JP 2024549135A JP 2025506729 A JP2025506729 A JP 2025506729A
Authority
JP
Japan
Prior art keywords
acetamide
isopropyl
pyrrolo
oxothieno
triazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024549135A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506729A5 (cg-RX-API-DMAC7.html
Inventor
オリヴィエ・アルノウド
フランク・コサネル
ロメル・ダジ-フェアン
グラディス・ロンゴ
フランク・マルゲ
オリヴィエ・ヴェニエル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JP2025506729A publication Critical patent/JP2025506729A/ja
Publication of JP2025506729A5 publication Critical patent/JP2025506729A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024549135A 2022-02-21 2023-02-20 チエノピロロトリアジン化合物、それらの調製及びそれらの治療的使用 Pending JP2025506729A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22315036 2022-02-21
EP22315036.8 2022-02-21
PCT/EP2023/054138 WO2023156643A1 (en) 2022-02-21 2023-02-20 Thienopyrrolotriazine compounds, their preparation and their therapeutic use

Publications (2)

Publication Number Publication Date
JP2025506729A true JP2025506729A (ja) 2025-03-13
JP2025506729A5 JP2025506729A5 (cg-RX-API-DMAC7.html) 2026-02-27

Family

ID=81326677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024549135A Pending JP2025506729A (ja) 2022-02-21 2023-02-20 チエノピロロトリアジン化合物、それらの調製及びそれらの治療的使用

Country Status (11)

Country Link
US (1) US20250129091A1 (cg-RX-API-DMAC7.html)
EP (1) EP4482841B1 (cg-RX-API-DMAC7.html)
JP (1) JP2025506729A (cg-RX-API-DMAC7.html)
KR (1) KR20240151767A (cg-RX-API-DMAC7.html)
CN (1) CN118843632A (cg-RX-API-DMAC7.html)
AU (1) AU2023222186A1 (cg-RX-API-DMAC7.html)
CA (1) CA3244475A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024010803A2 (cg-RX-API-DMAC7.html)
IL (1) IL314781A (cg-RX-API-DMAC7.html)
MX (1) MX2024010216A (cg-RX-API-DMAC7.html)
WO (1) WO2023156643A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116375728B (zh) * 2021-12-31 2025-06-10 成都赜灵生物医药科技有限公司 噻吩吡咯并三嗪酮类化合物及其用途
TW202545527A (zh) 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3及glp-1a組合療法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12168012B2 (en) * 2018-07-25 2024-12-17 Novartis Ag NLRP3 inflammasome inhibitors
US20230203064A1 (en) * 2020-04-23 2023-06-29 Janssen Pharmaceutica Nv Tricyclic compounds as inhibitors of nlrp3

Also Published As

Publication number Publication date
EP4482841A1 (en) 2025-01-01
CO2024010803A2 (es) 2024-08-20
AU2023222186A1 (en) 2024-10-10
MX2024010216A (es) 2024-09-02
CA3244475A1 (en) 2023-08-24
CN118843632A (zh) 2024-10-25
WO2023156643A1 (en) 2023-08-24
KR20240151767A (ko) 2024-10-18
EP4482841B1 (en) 2026-07-15
US20250129091A1 (en) 2025-04-24
IL314781A (en) 2024-10-01

Similar Documents

Publication Publication Date Title
AU2023263450B2 (en) Pyridazine compounds for inhibiting nlrp3
US10399989B2 (en) Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer
WO2018045911A1 (zh) 二氢嘧啶类化合物及其制备方法和用途
AU2020421426A1 (en) RORγt inhibitor, preparation method thereof and use thereof
US10316025B2 (en) Substituted piperazine compounds and methods of use and use thereof
CN104163813B (zh) 取代的吲哚化合物及其使用方法和用途
TWI826509B (zh) 作為vanin抑制劑之雜芳族化合物
JP2016532715A (ja) RORγ調節因子
JP6908623B2 (ja) テトラヒドロイソキノリン誘導体
JP2025510414A (ja) NLRP3誘導体として有用なピリド-[3,4-d]ピリダジンアミン誘導体
JP2022510351A (ja) バニン阻害剤としての複素芳香族化合物
KR20240151767A (ko) 티에노피롤로트리아진 화합물, 이의 제조 및 이의 치료 용도
WO2017156177A1 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
WO2020011147A1 (en) RORγ ANTAGONIST AND APPLICATION THEREOF IN MEDICINE
JP2025520541A (ja) コロナウイルス感染症の治療のための化合物
CN116354992A (zh) 一类pde4抑制剂及其在药物中的应用
JP2021530532A (ja) Trk阻害剤としてのイミダゾ[1,2−b]ピリダジン誘導体
JP2024501282A (ja) イミダゾ[1,2-a]ピリジニル誘導体と疾患の治療におけるその使用
CN105829321B (zh) 用于治疗癌症和炎性疾病的化合物
CN111315750B (zh) 作为mTORC1/2双激酶抑制剂的吡啶并嘧啶类化合物
JP2024501281A (ja) Irak4阻害剤としての2h-インダゾール誘導体及び疾患の治療におけるそれらの使用
WO2025155786A1 (en) Bicyclic tyrosine kinase 2 inhibitors and uses thereof
HK40083400A (en) RORγT INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF
EA051595B1 (ru) Соединения пиридазина для ингибирования nlrp3
CN118974059A (zh) 囊性纤维化跨膜传导调控因子的调节剂

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260218

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260218